April 15 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* ON 4 APRIL, EXECUTED A BINDING CONTRACT MANUFACTURING AND DISTRIBUTION AGREEMENT WITH MICELLE TECHNOLOGY AG
* AGREEMENT WITH MICELLE FOR RESEARCH SUPPORT, PRODUCTION & WHOLESALE DISTRIBUTION OF NATURAL ANTI-INFECTIVE BASED FORMULATION
* UNDER AGREEMENT, MGC TO HAVE RESPONSIBILITY FOR FUTURE CLINICAL TRIALS, EU GMP PRODUCTION & WHOLESALE DISTRIBUTION OF PRODUCT